Mortgage Marketshare Module
- Accurately track commercial and residential lending, measure sales performance against competition and market activity, identify high-performing competitors, and locate and target emerging markets.
  
  LEARN MORE >>
Loan Originator Module
- Access the largest and most comprehensive mortgage loan origination database in New England with round-the-clock interactive access and weekly trend updates.
  
  LEARN MORE >>
Marketing Lists
- Gain access to the most accurate and detailed transaction information in the country and offers a range of marketing lists for more than 130 million households (covering 94% of the U.S. population).
  
  LEARN MORE >>
Custom Research
- Powered by one-of-a-kind real estate, mortgage, and loan origination data, The Warren Group provides custom solutions for your research projects, database expansion, and strategic planning.
  
  LEARN MORE >>
Real Estate Records Search
- Access the largest and most complete real estate database in New England, including sales, price trends, liens and foreclosures.
  
  LEARN MORE >>

BioMed Realty Trust Prices Public Offering Of 11.5M Shares

Apr 14, 2010 | Reprints | Unlock Link | Print

BioMed Realty Trust Inc., a life science property owner with a large presence around Boston, has priced its public offering of 11.5 million shares of its common stock at $17.25 per share.

The offering is expected to close on or about April 19. Gross proceeds from the offering will be approximately $198.4 million. BioMed expects to use the net proceeds of the offering to repay a portion of the outstanding indebtedness under its $720 million unsecured line of credit and for other general corporate and working capital purposes. All of the shares are being sold by the company.

BioMed has also granted the underwriters a 30-day option to purchase up to an additional 1.7 million shares to cover over-allotments, if any. Raymond James & Assoc. Inc., Morgan Stanley & Co. Inc., UBS Securities LLC, Wells Fargo Securities LLC and KeyBanc Capital Markets Inc. are the joint book-running managers for the offering.

Commercial & Industrial